A Case of Cerebral Infarction Following Intravenous Immunoglobulin Therapy in a Patient with Guillain-Barre Syndrome.
- Author:
Sa Yoon KANG
1
;
Ji Hoon KANG
;
Ji Soo KIM
Author Information
1. Department of Neurology, College of Medicine, Cheju National University, 1 Ara 1-dong, Jeju-si, Jeju, 690-756, Korea. neurokang@cheju.ac.kr
- Publication Type:Case Report
- Keywords:
Intravenous immunoglobulin;
Guillain-Barre Syndrome;
Cerebral infarction
- MeSH:
Acute Kidney Injury;
Aged;
Cerebral Infarction*;
Guillain-Barre Syndrome*;
Humans;
Immunization, Passive*;
Immunoglobulins*;
Immunoglobulins, Intravenous;
Meningitis, Aseptic;
Stroke
- From:Journal of the Korean Neurological Association
2003;21(2):217-219
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. Although IVIg is generally regarded as being safe, there are reports of acute renal failure, aseptic meningitis, and unexplained stroke or thromboembolic events in elderly patients. We report a patient with Guillain-Barre syndrome who developed a cerebral infarction following intravenous immunoglobulin therapy.
